As of 2025-05-31, the Fair Value of Bukwang Pharm Co Ltd (003000.KS) is -58.36 KRW. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4,005.00 KRW, the upside of Bukwang Pharm Co Ltd is -101.46%.
With the market price of 4,005.00 KRW and our fair value calculation, Bukwang Pharm Co Ltd (003000.KS) is not a good investment. Investing in 003000.KS stocks now will result in a potential loss of 101.46%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -7,203.00 | -916.62 | -2,474.85 | -31,329.66 | -2,641.33 | -8,913.09 |
| YoY growth | 2.82% | 87.27% | -170.00% | -1,165.92% | 91.57% | -230.85% |
| Market Cap (mil) | 274,142.25 |
| P/E | |
| Forward P/E | 258.01x |
| EPS | -11.67 |
| Avg earnings growth rate | -230.85% |
| TTM earnings | -798.97 |